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Display of wasp venom allergens on the cell
surface of Saccharomyces cerevisiae
Irina Borodina1, Bettina M Jensen2, Ib Søndergaard1, Lars K Poulsen2*
Abstract
Background: Yeast surface display is a technique, where the proteins of interest are expressed as fusions with
yeast surface proteins and thus remain attached to the yeast cell wall after expression. Our purpose was to study
whether allergens expressed on the cell surface of baker’s yeast Saccharomyces cerevisiae preserve their native
allergenic properties and whether the yeast native surface glycoproteins interfere with IgE binding. We chose to
use the major allergens from the common wasp Vespula vulgaris venom: phospholipase A1, hyaluronidase and
antigen 5 as the model.
Results: The proteins were expressed on the surface as fusions with a-agglutinin complex protein AGA2. The
expression was confirmed by fluorescent cytometry (FACS) after staining the cells with antibody against a C-tag
attached to the C-terminal end of the allergens. Phospholipase A1 and hyaluronidase retained their enzymatic
activities. Phospholipase A1 severely inhibited the growth of the yeast cells. Antigen 5 - expressing yeast cells
bound IgE antibodies from wasp venom allergic patient sera but not from control sera as demonstrated by FACS.
Moreover, antigen 5 - expressing yeast cells were capable of mediating allergen-specific histamine release from
human basophils.
Conclusions: All the three major wasp venom allergens were expressed on the yeast surface. A high-level
expression, which was observed only for antigen 5, was needed for detection of IgE binding by FACS and for
induction of histamine release. The non-modified S. cerevisiae cells did not cause any unspecific reaction in FACS or
histamine release assay despite the expression of high-mannose oligosaccharides.
In perspective the yeast surface display may be used for allergen discovery from cDNA libraries and possibly for
sublingual immunotherapy as the cells can serve as good adjuvant and can be produced in large amounts at a
low price.
Background
Identification and characterization of allergenic com-
pounds is essential for development of advanced compo-
nent-resolved allergy diagnostics and treatment [1,2].
Single allergens can be identified either by resolving an
allergenic extract into single proteins or by recombi-
nantly expressing a library of allergenic genes in a host
organism. In the later approach phage display in E. coli
is commonly used [3,4]. However, E. coli is known to
fail to express a number of eukaryotic proteins due to
the lack of foldases and chaperones, which are impor-
tant for the correct folding of proteins. Most allergens
have conformational IgE epitopes, which might disap-
pear if the protein is folded incorrectly. This can repre-
sent a limitation of a phage display. Yeast offers an
alternative approach for display and selection of antigens
and antibodies. Firstly, it provides a wider repertoire of
correctly folded and glycosylated proteins, secondly, it
allows a more convenient and faster screening of posi-
tive clones by fluorescent-activated cell sorting. Bowley
et al. [5] compared phage and yeast display for their
ability to express HIV-1 immune scFv cDNA library.
The obtained clones were screened with the same
selecting antigen (HIV-1 gp120). Yeast library was far
superior to the phage display library selecting all the
scFv identified by phage display and twice as many
novel antibodies. In another study Wadle et al. [6] iden-
tified 33 novel breast cancer-related antigens using yeast
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surface display library, of these only four were found
previously when using bacterial-based libraries. In addi-
tion to being useful for novel antigens discovery, the
yeast display can be used in various other applications
such as protein engineering, immunoassays, affinity pur-
ification and as vaccines [7]. Baker’s yeast Saccharo-
myces cerevisiae has GRAS (generally regarded as safe)
status, which simplifies its use in pharmaceutical appli-
cations. To the best of our knowledge, there are no pre-
vious literature reports of yeast surface display
technology applied to allergens. A major obstacle in the
application of yeast surface display for expression of
allergens could be interference from the high-mannose
oligosaccharides, which may either bind IgE or hinder
IgE binding to the peptide-determinant. IgE antibodies
directed towards carbohydrate epitopes (cross-reactive
carbohydrate determinants, CCDs) are common in sera
of patients allergic to insect venoms and plant allergens
[8]. For example, the anti-CCD IgE were found in 28%
of honey-bee venom allergic patients [9], 33% of grass-
allergic patients [10], and 45-55% of carrot-celery aller-
gic patients [11,12]. However, a number of studies have
shown that the anti-CCD IgE are commonly directed
towards core a1,3-fucose, which does not occur in yeast
[8,13].
There are several systems that allow display on the
yeast cells, based on a-agglutinin, a-agglutinin or floccu-
lin proteins. A- and a-agglutinins mediate the cell-cell
adhesion during the yeast cell mating and are located
on the outmost surface of yeast cells. a-type mating cells
express a-agglutinin, which consists of AGA1 subunit
attached to the cell wall by glycosylphosphatidylinositol
(GPI) anchor and of a small AGA2 subunit connected
with AGA1 by disulfide bridges. The DNA sequence
encoding protein of interest can be fused to the C-terminal
of aga2 gene and transformed into an aga1-overexpressing
S. cerevisiae strain, which will result in the protein being
expressed as fusion with AGA2 on the outmost cell
surface of the yeast cells (Figure 1).
We have chosen common wasp Vespula vulgaris
venom allergens as the model for testing allergen
expression on the surface of S. cerevisiae. The diagnosis
and treatment of stinging insect allergies as wasp and
honey bee have been used as an allergy model for sev-
eral decades [14]. After the substitution of whole body
extract therapy by venom extracts in 1979, the efficacy
of treatment reached 95% for wasp venom allergy and
80% for honey bee venom allergy [15]. The composition
of the vespid venoms has been extensively studied and
the major allergic components have been identified [16].
On average there is 1.7-17 μg of protein in a vespid
venom sac with 3.3% being phospholipase A1, 1.5% hya-
luronidase, and 8.1% antigen 5, which all can cause
allergic response in humans [17,18]. Phospholipase A1 is
a 35 kDa non-glycosylated enzyme; antigen 5 is a
23 kDa non-glycosylated protein with so far unidentified
function [19]. Hyaluronidase is a 45 kDa glycoprotein,
in which insect-type glycosylation with a1,3-fucoses is
believed to be responsible for cross-reactivity with sera
of honey-bee sensitized patients [8,20]. Three allergens
from the common wasp venom have been expressed
recombinantly in E. coli [21-24] and insect cells [25,26]
and antigen 5 was additionally expressed in yeast Pichia
pastoris [23].
Here we describe expression and characterization
including the biological activity of three major wasp
venom allergens phospholipase A1, hyaluronidase and
antigen 5 on the surface of S. cerevisiae cells.
Results and discussion
Cloning of allergen genes
The genes encoding major wasp allergens phospholipase
A1 (Ves v 1.0101, further called Ves v 1), hyaluronidase
(Ves v 2.0101, further called Ves v 2) and antigen 5 (Ves
v 5.0101, further called Ves v 5) were amplified from the
total RNA of common wasp V. vulgaris by RT-PCR. We
also attempted amplifying the gene, encoding a hyaluro-
nidase-like protein without enzymatic activity (Ves v
2.0201), which was found previously in V. vulgaris and
V. germanica venoms [25], but only non-specific gene
products of ves v 2.0201 were obtained. The genes were
subsequently cloned into TOPO vector and sequenced.
There were a few differences from the gene sequences
reported by King’s group [21,27]. Phospholipase A1-
encoding gene had six variations, five of which were sin-
gle point mutations and one was a change of all
the three nucleotides in a triplet. For hyaluronidase
4 nucleotide discrepancies from the previously published
sequence were observed, all were silent point mutations;
hence, the amino acid sequence remained as reported
before. Hyaluronidase is known to be more conserved
than phospholipase A1. So common wasp hyaluronidase
has 92% identity with amino acid sequence of a homo-
log from white faced hornet, while phospholipase A1
has only 67% identity [21]. The sequence of antigen
5-encoding gene had six single nucleotide variations
from King’s sequence, four of which have been reported
elsewhere (GenBank accession nr. AJ238849). It is
important to note that neither of the variations was
positioned in the predicted active site (UniProt http://
www.uniprot.org) or affected cysteins, hence the disul-
fide bond formation should not be disturbed.
In general, the variations in the gene sequences can be
explained firstly by different geographical locations as
the wasps in King’s work were from Vespa Labs (PA,
USA), while our wasps were from Denmark in Europe.
Secondly, it can come from polymorphism, which has
been described even for genes within the same vespids’
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population. Thus Hoffman sequenced Ves m 1 protein
from V. maculifrons and Dol m 1.02 from white faced
hornet Dolichovespula maculate and found 3 amino
acids variant positions in Ves m 1 and 2 variants posi-
tions in Dol m 1.02 [28]. Soldatova, Kochoumian and
King [29] described 4 natural variants of dol m 1.01
mRNA sequence.
Expression of allergens on the surface of yeast
The genes were PCR-amplified with overhangs and
directionally cloned into a-agglutinin expression vector
to make an in-frame fusion with aga2 gene (Figure 1,
2). The plasmids were transformed into S. cerevisiae
strain EBY100, which can overexpress another protein
of the a-agglutinin system - AGA1. When the cells were
grown on inducing medium, the AGA1 and AGA2-aller-
gen fusion was expressed and exported on the cell sur-
face as a complex held by disulfide bonds (Figure 1). A
51-amino acid long fragment of human CD20 protein
was used as a non-allergen control. CD20 antigen is
expressed on the surface of mature B-lymphocytes and
to the best of our knowledge there are no reports on
the presence of IgE antibodies to this autologous protein
in human sera. The allergens also contained a 10 amino
acid-long C-myc tag at the C-terminal. The expression
of allergens was quantified by fluorescent cytometry
after staining the expressing cells with anti-C-myc anti-
body conjugated with AlexaFluor488 (Table 1). The
expression of antigen 5 was almost just as high as of the
reference protein CD20; however there was very weak
expression of phospholipase A1 and hyaluronidase. We
speculate that these allergens might be toxic to the yeast
cells because of their enzymatic activity. The a-aggluti-
nin vector is a replicating vector, which is retained in
the cells due to tryptophan selection. As tryptophan is
an amino acid needed in very small amounts, the selec-
tion is not very strong and the vector can be lost by the
cells. To circumvent the problem we introduced zeocin
resistance marker into the vector and performed cultiva-
tion in the presence of zeocin antibiotic so that constant
selective pressure was applied (Figure 3, Table 1). The
expression level of CD20 and antigen 5 improved from
when only tryptophan selection was used; now corre-
spondingly 74.9 and 73.4% of the cells expressed the
Figure 1 The principle of surface display using a-agglutinin system. The allergen of interest (here shown ves v 1) is cloned in-frame with
aga2 gene and introduced into a yeast strain that can overexpress aga1 gene. The resulting proteins, Aga1 and Aga2-allergen fusion, get
connected by disulfide bonds in the secretion process and are exported together on the surface of the cell where Aga1 remains attached to the
cell wall by the glycosylphosphatidylinositol (GPI) anchor.
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proteins against 43.7 and 32.8% before. Moreover
increased mean ratio indicated higher amount of dis-
played protein per cell. The hyaluronidase and phospho-
lipase A1 expressing cells had increased
autofluorescence, which can be a sign of stress. About
5-4% of the cells expressed phospholipase A1 and hya-
luronidase, though the amount of allergens per expres-
sing cell was much lower than for antigen 5 or CD20, as
can be judged from the low mean ratios (Table 1).
Besides improving the allergen expression introduction
of zeocin selection also had a positive effect on selecting
correct yeast transformants as the false positives were
fully eliminated.
In order to evaluate toxicity of the allergens to the
expressing yeast cells we performed growth rate experi-
ments, which showed that the phospholipase A1 expres-
sion decreased the maximal specific growth rate by 70%
and 82% when cells were grown without or with zeocin
selection correspondingly (Figure 4). In contrast, addi-
tion of phospholipase A1 (Lecitase® Ultra) directly into
Table 1 Quantification of allergen expression on the surface by FACS analysis
% of expressing cells Geometrical mean ratio
Protein Tryptophan selection Tryptophan and zeocin selection Tryptophan selection Tryptophan and zeocin selection
None 2.4 - 1.0 -
CD20 43.7 ± 1.0 74.9 ± 1.3 3.1 ± 0.2 11.5 ± 0.3
Phospholipase A1
(Ves v 1)
3.3 5.6 1.2 1.1
Hyaluronidase (Ves v 2) 5.1 5.3 1.3 1.5
Antigen 5 (Ves v 5) 32.8 73.4 2.2 9.3
The cells were stained with anti-C-myc antibody conjugated with AlexaFluor488 and analyzed by fluorescent flow cytometry. The intensity of the green
fluorescent signal was measured. For calculation of percentage of expressing cells and geometrical mean ratio the labeled cells were compared with non-labeled
cells. The labeling of CD-20-expressing cells was performed in triplicates and the average and standard deviation are shown.
Figure 2 Vector map of a surface display vector with zeocin resistance. The original vector pCTCON2 [36] was modified by addition of
zeocin resistance cassette, containing yeast TEF1 promoter, prokaryotic EM7 promoter, zeocin resistance gene ble from Streptoalloteichus
hindustanus and transcription terminator CYC1. The allergen genes were cloned flush downstream the flexible peptide linker (Gly4Ser)3, which
was connected to aga2 gene under control of galactose-inducible promoter GAL1. The allergen genes were also cloned in-frame with
C-terminal myc tag. The vector additionally contained ampicillin resistance marker Amp(R) for selection in E. coli, tryptophan selection marker
TRP1 for selection in S. cerevisiae, pUC origin of replication for E. coli, and CEN6/ARSH4 origin for vector replication in S. cerevisiae.
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Figure 4 Maximal specific growth rates of yeast cells expressing reference protein (CD20) and wasp venom allergens. Maximal specific
growth rates of cells grown on galactose under tryptophan selection (first columns) or combined tryptophan and zeocin selection (second
columns) were measured in triplicates. The error bars show standard deviation. Two extra columns demonstrate the effect of extracellular
addition of phospholipase A1 or hyaluronidase on the growth rate of CD20-expressing cells.
Figure 3 Fluorescent cytometry of yeast cells expressing reference protein (CD20) and wasp venom allergens. The cells induced on
galactose under selective pressure of tryptophan and zeocin to maintain expression plasmid were labeled with AlexaFluor488-conjugated anti-
C-myc antibody and analyzed by FACS. The grey background shows non-stained cells.
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the growth medium with CD20-expressing yeast in the
amount of 3.3 u/ml (which is about an order of magni-
tude higher that the expressing cells can accumulate at
the given conditions) did not have a reverse effect on
the growth rate. Most likely the cells are protected from
the extracellular phospholipase by their cell wall and
therefore are not influenced by its presence in the med-
ium, while the phospholipase which is produced inside
the cells damages them during synthesis and secretion.
The hyaluronidase expression caused a statistically sig-
nificant decrease in the maximal specific growth rate
(p < 0.05), though much less pronounced than the
phospholipase A1: 8% and 11% for cells grown with
tryptophan or with tryptophan-zeocin selection corre-
spondingly. The external addition of Streptomyces
hyalurolyticus hyaluronidase at the concentration of
17 u/ml did not affect the growth (the enzyme activity
exceeds the recombinant hyaluronidase activity that the
cells can accumulate by an order of magnitude).
Expression of phospholipase A1 and hyaluronidase
might also be limited by the capacity of yeast endoplas-
mic reticulum to fold these heterologous proteins,
which would result in unfolded protein response, char-
acterized by loss of protein expression and various stress
reactions [30]. Lower cultivation temperatures have been
shown to reduce the unfolded protein response and can
be attempted in future studies to improve the cell sur-
face expression of difficult proteins [31].
Enzymatic activity of the surface-bound allergens
We tested the enzymatic activity of the yeast cells
expressing phospholipase A1 and hyaluronidase. The
enzymatic activity of phospholipase A1 was measured to
0.08 and 2.6 units/109 cells when grown with only tryp-
tophan or tryptophan/zeocin selection correspondingly.
Hence the addition of zeocin selection improved the
expression of phospholipase A1 by an order of magni-
tude. For the hyaluronidase an improvement was also
found. Here the numbers were 31 and 90 units/109
cells, which is a 3-fold increase.
Binding IgE from patient serum by FACS
The ability of the surface-expressed allergens to bind
human IgE antibodies was tested by incubating the
yeast cells with serum, staining with anti-IgE biotiny-
lated antibody and streptavidin-phycoerythrin and ana-
lyzing the cells by flow cytometry (Figure 5). A
serumpool from five wasp venom allergic patients was
used as positive control and a serumpool from healthy
individuals was used as negative control. Preceding
FACS analysis the pool of wasp venom allergic sera was
tested by western blot with venom extract to confirm
that IgE against all the three allergens were present
(data not shown).
The yeast cells without surface protein or expressing
the reference CD20 protein did not bind IgE antibodies
from either serumpool. Antigen 5-expressing cells
bound IgE from the wasp venom allergic serumpool, but
not from the control serumpool. Hyaluronidase-expressing
cells bound very limited IgE but from both serumpools
indicating an unspecific IgE effect. The binding of IgE to
phospholipase A1 could not be detected presumably
because of the low expression level. Double staining with
anti-C-myc antibody and IgE confirmed that it is the cell
population that binds anti-C-myc and hence has the
allergen protein expressed that also gives a signal for IgE
binding (Figure 6).
Histamine release assay
The allergen-expressing cells were tested for their ability
to mediate a histamine release from blood basophils
sensitized with IgE from wasp venom allergics or
healthy controls. Basophils were challenged with wasp
venom to illustrate the wasp venom specific response
and as seen in Figure 7, only the basophils sensitized
with serum from wasp venom allergics released
histamine.
Comparable to the IgE-binding analysis, the CD20-
expressing cells did not mediate a histamine release.
Hyaluronidase did not mediate a histamine release sup-
porting that the unspecific IgE binding seen with FACS
is not biologically relevant. In 1 out of 4 experiments
phospholipase A1 mediated an unspecific histamine
release since both wasp venom sensitive and control
basophils were activated (data not shown). Antigen 5
however did activate the wasp venom sensitive basophils
and a dose response curve could be generated as seen in
Figure 7A. The potency of 106 antigen 5 - expressing
cells correspond to about 1 ng of wasp venom extract.
Antigen 5 did not activate basophils sensitized with con-
trol serum.
Conclusions
The aim of the study was to test whether allergenic pro-
teins retained their IgE-binding activity when expressed
on the surface of yeast cells. Moreover, we aimed at
studying whether allergen displaying yeast cells
expressed allergenic activity in a biological model of the
allergic reaction: the basophil histamine release test. We
chose wasp venom allergens as the model allergens,
which proved to be a difficult case due to the cellular
toxicity of one allergen (phospholipase A1) and low
expression of another allergen (hyaluronidase) for
unknown reasons. However, some levels of expression
of both allergens were obtained and corresponding
enzymatic activities were detected, suggesting that the
proteins obtained a certain degree of their native confir-
mation. There have been no reports so far on
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Figure 5 Fluorescent cytometry analysis of cells binding to serum IgE. Binding of yeast cells to the IgE from sera. Red background shows
non-labeled cells, black line shows cells labeled with positive serumpool and the green line shows cells labeled with control serumpool.
Figure 6 Correlation between allergenic protein expression and binding to serum IgE. Double staining of cells expressing CD20 (left) or
Ves v 5 (right) with patient sera IgE and anti-C-myc antibody. The anti-C-myc binding is measured in FL1 and the IgE binding in FL2.
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recombinant expression of these two proteins in a yeast
host. The last allergen that we tested, antigen 5 was well
expressed on the surface of yeast cells; it retained IgE
binding and could induce allergen-specific histamine
release. The non-modified yeast showed neither IgE
binding in the FACS assay nor activity in the histamine
release assay.
The procedure for allergen expression on the surface
is fast and the cells can be tested directly for IgE bind-
ing by FACS and histamine release without the need for
recombinant protein purification. As an eukaryotic host,
yeast is more likely to fold eukaryotic proteins more effi-
ciently and to form disulfide bonds correctly, which
eliminates the need of refolding the proteins as after
expression in E. coli [32,33]. The proteins made by yeast
are also N-glycosylated [34], which is sometimes impor-
tant for proper folding as in the case of hyaluronidase
[35]. It should be mentioned that the glycosylation is of
high-mannose type and its interaction with human
immune system is largely unknown [8]. We, however,
did not observe IgE binding to yeast cells that could be
related to carbohydrate-determined IgE reactivity. The
immunogenic reactivity of antigen 5 should not be
related to CCD reactivity, because this protein is not N-
glycosylated neither in its native form in the venom nor
when expressed recombinantly in yeast P. pastoris [23].
The expression of allergens on the surface of yeast
cells presents new opportunities as identification of
novel allergens in yeast display cDNA libraries and
immunotherapy with yeast cells.
Methods
Patients
5 patients were chosen based on their serum IgE reac-
tivity with venom extract in ImmunoCap assay (Phadia),
all CAP class 4 or above. The equal volumes of sera
were pooled and used as the positive sera. The negative
control sera pool consisted of 3 sera from non-allergic
individuals as confirmed by negative histamine release
assay with wasp venom. The usage of patients’ sera in
the current study was approved by the local ethical
committee.
Chemicals
The chemicals were purchased from Sigma-Aldrich and
BD Biosciences. Zeocin™ was purchased from Invitrogen.
Anti-C-myc monoclonal mouse IgG antibody, conju-
gated to horse radish peroxidase, was purchased from
Invitrogen. Mouse monoclonal anti-C-myc antibody
(clone 9E10) conjugated with AlexaFluor® 488 was from
AbD Serotec. Biotin-conjugated mouse anti-human IgE
antibody (clone G7-26) and streptavidin-phycoerythrin
(PE) conjugate (SAv-PE) were from BD Biosciences.
Hyaluronic acid potassium salt from human umbilical
cord and hyaluronidase from Streptomyces hyalurolyti-
cus were from Sigma-Aldrich. The restriction enzymes
and T4 DNA ligase were from New England Biolabs
Inc. Vespula venom extract used in western blots was a
kind gift of Jørgen Nedergaard Larsen (ALK Abelló,
Hørsholm, Denmark). Vespula venom extract used in
histamine release assay was from ALK Abelló and con-
tained 136 μg/ml protein.
Strains and plasmids
The E. coli strains used for cloning were TOP10 and
DH10B, both deficient in recombinase (recA) and endo-
nuclease A (endA). The Saccharomyces cerevisiae strain
was EBY100 (a GAL1-AGA1::URA3 ura3-52 trp1 leu2Δ1
his3Δ200 pep4::HIS2 prb1Δ1.6R can1GAL), Trp-Leu-,
kindly provided by Dr. K. Dane Wittrup from MIT,
Figure 7 Basophil histamine release. Basophils sensitized with serum from wasp venom allergics (A) or healthy controls (B) were challenged
with wasp venom and yeast cells expressing CD20, Ves v 1, Ves v 2 or Ves v 5 (from surface display vectors with zeocin-resistance markers). The
results represent one experiment out of four. The wasp venom is diluted 3-fold in each step from the highest concentration of 222 ng venom
extract per sample.
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USA. The plasmid pCTCON2 was also a gift from K.
Dane Wittrup. Vector pPICZalphaA was purchased
from Invitrogen. For longer storage the E. coli strains
were stored in LB medium with 25% glycerol and yeast
strains were stored in YPD with 15% glycerol at -80°C.
Insects
Common wasps (V. vulgaris) were caught at two nests
in Denmark. The wasps were classified as V. vulgaris
based on their morphology: 15 mm-long body with
characteristic yellow and black colors, a black anchor on
the head, and black rings on the abdomen.
RNA isolation
The venom sacs were removed with tweezers and
immersed in RNAlater solution (Ambion, Inc.), stored
overnight at 4°C and then transferred at -20°C for
longer storage. For RNA isolation 10 venom sacs were
removed from the RNAlater solution, grinded in liquid
nitrogen, transferred to a FastPrep tube with 0.25-0.5
mm diameter acid-washed glass beads. 600 μl of RLT
buffer was added and the samples were homogenized in
a FastPrep FP120 machine (Qbiogene) at 2 cycles of 30
s with power set to 5.5. Further on the total RNA was
extracted using RNeasy Mini kit (Qiagen) according to
the manufacture’s instructions. The final RNA concen-
tration and purity was determined on spectrophot-
ometer and on electrophoresis gel.
Cloning of allergen genes
The genes encoding phospholipase A1 (Ves v 1), hyalur-
onidase (Ves v 2.0101) and antigen 5 (Ves v 5) were
amplified from the total RNA of V. vulgaris using RT-
PCR (Superscript III One-Step RT-PCR System with
Platinum Taq DNA Polymerase, Invitrogen). The gene
encoding hyaluronidase variant (Ves v 2.0201) could not
be amplified. As a positive control for RT-PCR reaction
we amplified fragments of 18 S and 28 S RNA. The pri-
mers used for RT-PCR reactions are shown in Table 2.
Two genes, ves v 1 and ves v 5, were amplified together
with their signal sequences. For the hyaluronidase (ves v
2) the signal sequence was not known, hence only the
part encoding mature protein was amplified. 2.5 μl of
the RT-PCR reaction were further used as a template in
a 100-μl PCR reaction with Expand High Fidelity poly-
merase (Roche Diagnostics) and with the same primers
to generate sufficient amounts of the fragment for clon-
ing. The PCR reaction product was separated on 1.1%
agarose gel stained with SYBR-safe (Invitrogen). The
fragments of the correct size were excised with a scalpel
and purified from the gel using GFX PCR DNA and gel
band purification kit (GE Healthcare). The fragments
were cloned into pCR®2.1-TOPO® vector, using TOPO
TA Cloning® kit (Invitrogen) and transformed into
chemically competent E. coli TOP10 cells. The transfor-
mants were selected on SOB plates with 20 mM MgCl2,
50 μg/ml kanamycin and 50 μg/ml X-gal. White colo-
nies were screened for the presence of the cloned frag-
ment using colony PCR with the fragment-specific
primers (the same as used for RT-PCR). 3-4 correct
clones were grown overnight and the plasmid was
extracted using GeneElute™ Plasmid Miniprep kit
(Sigma-Aldrich). After confirmation of the correct con-
struct by restriction, the plasmids were sequenced at
Eurofins MWG Operon or StarSEQ.
Construction of surface display vectors
The genes ves v 1, ves v 2 and ves v 5 were amplified
from the corresponding TOPO plasmids TOPO_vesv1,
TOPO_vesv2 and TOPO_vesv5 with forward and
reverse primers indicated in Table 2 (primers starting
with “SD”) using Expand High Fidelity polymerase
(Roche Diagnostics). The PCR products were separated
on 1.1% agarose gel, cut and purified from the gels
using GFX kit (GE Healthcare). The purified PCR frag-
ments were restricted with NheI and BamHI enzymes
and cloned into pCTCON2 vector, which was digested
with the same restriction enzymes and gel purified. The
ligation of the vector and the insert was performed with
T4 DNA ligase (New England Biolabs, UK) at room
temperature for 30 min. The ligation mixture was trans-
formed into chemically competent E. coli DH10B cells
and the transformants were selected on Luria-Bertani
(LB) agar plates with 100 μg/ml ampicillin. The trans-
formants carrying inserts were identified by colony PCR
with the same primers as above. The correct transfor-
mants were grown in LB broth with 100 μg/ml ampicil-
lin overnight and the plasmids were isolated using
GenElute Miniprep kit (Sigma-Aldrich). The resulting
surface display vectors were named pSD_vesv1,
pSD_vesv2 and pSD_vesv5. The sequence of the plas-
mids was confirmed by restriction digestion and by
sequencing.
Construction of surface display vectors with zeocin
resistance
The zeocin resistance cassette was PCR-amplified with
zeo_fw and zeo_rv primers (Table 2) using plasmid
pPICZalphaA as the template. The resulting fragment
was purified from the gel, digested with KpnI and
cloned into surface display vectors pSD_vesv2 and
pSD_vesv5 cut with the same enzyme. The transfor-
mants were selected on LB plates with 100 μg/ml ampi-
cillin and 25 μg/ml zeocin, giving pSD_vesv2_zeo and
pSD_vesv5_zeo. For the construction of pSD_vesv1_zeo
vector a different strategy was applied because the vesv1
gene contained a KpnI restriction site. The PCR-ampli-
fied and KpnI-digested zeocin resistance cassette was
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ligated with pCTCON2 vector digested with KpnI and
the ligation mixture was transformed into E. coli. After
selection of the zeocin-resistant clones, the plasmid
pCTCON2_zeo was isolated and the vesv1 gene was
cloned into it in the same way as it was cloned into
pCTCON2 vector above.
Yeast transformation
The surface display plasmids pCTCON2, pCTCON2_-
zeo, pSD_ves1, pSD_vesv2, pSD_vesv5, pSD_vesv1_zeo,
pSD_vesv2_zeo, pSD_ves5_zeo were transformed into S.
cerevisiae strain EBY100 as following. A single colony of
S. cerevisiae was inoculated in 2 ml YPD medium over-
night at 30°C with shaking. Next morning 50 ml YPD in
a 500-ml shake flask was inoculated with the overnight
culture to the start optical density (OD600) of 0.2 and
grown until OD600 of 1.4-1.6. The cells were collected
by centrifugation at 3,000 × g for 5 min, washed twice
with 50 ml MilliQ water and once with 10 ml transfor-
mation buffer (20 mM HEPES in 1 M sorbitol). The
cells were eventually resuspended in 100 μl transforma-
tion buffer. 40 μl of the cell suspension were mixed with
5 μl of plasmid preparation, electroporated on Gene
Pulser (Bio-Rad Laboratories) at 1.5 kV. 1 ml transfor-
mation buffer was added to the cells immediately after
electroporation and the cell suspension was transferred
to a 15 ml tube. After incubation at 30°C for 1 hour the
cells were centrifuged, resuspended in 100 μl buffer and
volumes of 10 and 50 μl were plated on tryptophan-defi-
cient SDCAA plates [36]. When transforming vectors
with zeocin resistance cassettes the SDCAA was supple-
mented with 100 μg/ml zeocin. Colonies appeared after
2-3 days of incubation at 30°C. The presence of the vec-
tor was confirmed by colony-PCR using gene-specific
primers.
Cultivation and induction of yeast cells
The cultivation medium was SDCAA and SGCAA as
described in Chao et al. [36], except that the phosphate
concentration was reduced to 50 mM in order to avoid
zeocin inhibition by high salt concentration. The
SDCAA medium contained 20 g/L dextrose as carbon
source, while in SGCAA medium the dextrose was
replaced by the same amount of galactose. A single
Table 2 List of primers
Primer name Sequence Application
vesv1_fw ATGGAAGAAAATATGAATTTAAAG Cloning genes from RNA
vesv1_rv TTAAATTATCTTCCCCTTGTTATTG
vesv2.0101_fw TCCGAGAGACCGAAAAGAG
vesv2.0101_rv TTAGTTGACGGCTTCTGTCAC
vesv2.0201_fw GACAGAACAATTTGGCCTAAG
vesv2.0201_rv CTAAAAGTTTAACGGTGTGTTTTC
vesv5_fw ATGGAAATTAGTGGGCTC
vesv5_rv TTACTTTGTTTGATAAAGTTCCTC
28SrRNAvesv_fw AGCGTCAGCGGCGCTG
28SrRNAvesv_rv GAGACACTGACCGCGCTTG
SD_vesv1_fw NheI
ATCAGCTAGCGGACCCAAATGTCCTTTTAATTC
Cloning genes into surface display vector
SD_vesv1_rv BamHI
CGATGGATCCAATTATCTTCCCCTTGTTATTGC
SD_vesv2_fw NheI
ATCAGCTAGCTCCGAGAGACCGAAAAG
SD_vesv2_rv BamHI
CGATGGATCCGTTGACGGCTTCTGTC
SD_vesv5_fw NheI
ATCAGCTAGCAACAATTATTGTAAAATAAAATG
SD_vesv5_rv BamHI
CGATGGATCCCTTTGTTTGATAAAGTTC
zeo_fw KpnI
TAGATTGGTACCCCCACACACCATAGCTTC
Cloning zeocin resistance gene
zeo_rv KpnI
GTCCTCGGTACCAGCTTGCAAATTAAAGC
The first group of primers was used for amplification of four allergen genes and control 18 S rRNA from wasp venom sac RNA. The second group of primers was
used for generating fragments with NheI and BamHI overhangs for cloning into surface display vector. The last set of primers was used for cloning zeocin
resistance cassette with KpnI overhangs. The restriction sites are underlined.
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colony was inoculated in 20 ml SDCAA medium in 500-
ml baffled flask and grown overnight at 30°C with shak-
ing at 150 rpm to an OD600 of about 1-2. The cells
were harvested by centrifugation and resuspended in
SGCAA medium to OD600 of 1. The cultures were
transferred into 500-ml baffled shake flasks and grown
at room temperature (22-23°C) for 30 hours. The cul-
tures were stored at +4°C until analysis, but never
longer than one week.
Growth experiment
For the growth rate experiments the cells were grown in
SDCAA as above and then resuspended to the OD600 of
0.1 in SGCAA medium with or without 100 μg/ml zeo-
cin. The cell suspensions were pipetted into a sterile 96-
well flat-bottom microtiter plate (100 μl suspension per
well) (Nunc 96-microwell plate from Thermo Scientific).
Sterile SGCAA media was used as the background refer-
ence. All the samples were run in triplicates. The plates
were covered by air-permeable transparent film and sha-
ken during overnight incubation at room temperature.
The OD600 readings were performed automatically every
half an hour with Multiscan Accent (Thermo Scientific).
The data was exported into Excel (Microsoft) and used
to calculate the maximum specific growth rates during
the exponential growth phase.
SDS-Polyacrylamide Gel Electrophoresis
The gel was a pre-cast 10% NuPAGE® Novex® Bis-Tris
electrophoresis gel from Invitrogen. The protein size
marker was unstained or pre-stained PageRuler™ protein
ladder from Fermentas (Germany). The samples were
mixed with NuPAGE® LDS sample buffer (4×) and
NuPAGE® reducing agent (10×) and heated at 70°C for
10 min before loading on the gel. The electrophoresis
was performed at a constant voltage of 200 V for 35
min. The gel was used for western blot or stained with
silver stain (Fermentas, Germany).
Western blot
For western blot the proteins were elecrophoretically
transferred onto 0.2 μm PVDF membrane Amersham
Hybond™-P (GE Healthcare) using Mini Trans-Blot®
electrophoretic transfer cell (Bio-Rad Laboratories) at
100 V for 1 hour. The transfer was done in 25 mM
Tris, 192 mM glycine, and 20% v/v ethanol buffer.
Detection of expression with anti-C-myc antibody
The cells grown in SGCAA were analyzed for expression
of the allergen using Alexa488-conjugated anti-C-myc
antibody. The analysis was possible because the aller-
gens were cloned in-frame with c-myc epitope present
in the pCTCON2 vector. The C-myc epitope was posi-
tioned at the C-terminal of the proteins. The cell
volume containing about 106 yeast cells (OD600 of 1 cor-
responds to about 107 cells/ml) was moved to an epend-
off tube with 1 ml blocking buffer (5 g/L skim milk
powder, 50 mM Tris, 150 mM sodium chloride, 0.1 g/L
Tween 20, pH 7.5). The content was mixed by inversion
and centrifuged at 4,000 × g for 2 min. The supernatant
was removed with a pipette and the cells were resus-
pended in 45 μl blocking buffer and 5 μl anti-C-myc-
Alexa488 and incubated in the dark at room tempera-
ture for 1 hour with occasional mixing. Non-labeled
controls with omission of antibody were prepared as
well. The cells were washed twice with cold TBST buffer
(50 mM Tris, 150 mM sodium chloride, 0.1 g/L Tween
20, pH 7.5) and resuspended in 500 μl TBST. The cells
were analyzed by flow cytometry on Cytomics FC 500
MPL flow cytometry system with MXP software (Beck-
man Coulter). The cell debris and other small particles
were eliminated from analysis by setting the forward
scatter threshold. Normally about 95-97% of the cells
were gated.
Binding of IgE from patient serum
The induced cells were analyzed for binding IgE from
patients’ sera. The cell volume containing about 106
yeast cells was mixed with PBSF buffer (8 g/L NaCl, 0.2
g/L KCl, 1.44 g/L Na2HPO4, 0.24 g/L KH2PO4, 1 g/L
bovine serum albumin, pH 7.4) to the total volume of 1
ml. The cells were centrifuged at 4,000 × g for 2 min
and washed with 1 ml PBSF buffer. The cells were pel-
leted again and resuspended in 50 μl PBSF. 12.5 μl of
cell suspension was mixed with 12.5 μl of positive or
negative sera pool and incubated at room temperature
for 1.5 hours with occasional mixing. The cells were
washed with 1 ml ice-cold PBSF twice and mixed with
biotinylated anti-IgE antibody diluted 1:200 in PBSF
(total volume of 80 μl). For the double labeling the anti-
C-myc antibody was added together with anti-IgE anti-
body at the dilution 1:10. The mix was incubated at 4°C
for 1 hour. The cells were centrifuged and washed twice
with ice-cold PBSF and mixed with streptavidin-phy-
coerythrin diluted 1:1000 in PBSF (total volume of 100
μl). The mix was incubated at 4°C for 30 min, the cells
were washed twice with ice-cold PBSF, resuspended in
400 μl PBSF and analyzed by flow cytometry as above.
Histamine release assay
Peripheral blood mononuclear cells (PBMCs) from buffy
coat blood (n = 3, non-allergic donor, anti-IgE respon-
sive cells) were isolated by Lymphoprep gradient centri-
fugation. IgE was stripped off the basophils by a
rebound in pH from 7.4 to 3.55 and back to 7.4. The
PBMCs were then incubated 1 hour with wasp patient
or control pool (non-allergic) serum to re-sensitize the
basophils, which subsequently were mixed with
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erythrocytes and challenged in glass fiber coated micro-
titer plates with control yeast expressing CD20 or yeast
expressing phospholipase A1 (Ves v 1), hyaluronidase
(Ves v 2) or antigen 5 (Ves v 5). Released histamine
bound to the glass fibers was coupled to o-phtahaldial-
dehyde, stabilized by HCLO4, and measured fluorome-
trically as described previously [37]. Results were
expressed as percentage of total cellular histamine con-
tent and were considered positive when > 10%.
Enzymatic assays
The enzymatic activity of hyaluronidase was measured
by turbidimetric method of Dorfman [38]. The volumes
were reduced for microtiter plate format. After incuba-
tion with hyaluronic acid the mixture was centrifuged to
remove the cells and only supernatant was added to the
acid albumin solution. Hyaluronidase from S. hyaluroly-
ticus was used as a standard.
Phospholipase A1 enzymatic assay was performed
using EnzChek® phospholipase A1 assay kit from Invi-
trogen according to the manufacturer’s protocol. The
controls without reagents addition were performed to
ensure that the yeast cells did not fluoresce at the used
wavelength. The Lecitase® Ultra (Invitrogen) was used as
a standard.
The non-transformed yeast cells and the yeast cells
expressing CD20 protein were used as the negative con-
trols in both assays.
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